Doxx, an Egyptian healthtech startup in a seed round raised $1.5 million.
Founded in 2020, Doxx connects users to professionals and institutional healthcare providers — including pharmacies, labs, radiology centres, and insurance companies — to support patients’ medical journey, increase accuracy, as well as improve the quality of service while reducing healthcare costs for the patient.
Doxx was founded on the principle of empowering patients. It has since acquired 2600 doctors, 12 Polyclinics and 52 pharmacies. 26 medical labs have been added to its portfolio, as well as 10 scan centers.
“Guided by our commitment to close the gap between the patients and the healthcare community and increase the quality-of-care delivery, we developed a comprehensive and inclusive platform, putting patients’ needs at the centre of our focus while providing benefits to all healthcare stakeholders and participants,” said Sherif Broudy — Founder and CEO of Doxx.
“We designed Doxx to be the trusted patient and doctor-friendly app in single-source care. We help patients take control of their journey and medical needs and address their healthcare needs well beyond booking features and prescription fulfilment in a single easy-to-use platform that will be their lifelong companion.”
“We believe that Doxx developed a truly superior technology well beyond any existing point solutions that put the focus on the patient while creating value for all healthcare stakeholders and value chain participants.
“Driven by the team’s comprehensive knowledge of the market and a mission to transform the patient’s journey and support by a sustainable business was fundamental to our decision to capitalise Doxx to ensure a strong go-to-market launch and sustainable growth,” explained Ash Rofail — Founder and General Partner at Doxx.
Through its extensive network of pharmaceutical partners, the app works to provide competitive prices for drugs.
“As medical professionals and doctors, it has always been our vision to be able to track our patients’ medical history and files, as it is essential to be able to diagnose and prescribe the correct treatment. Doxx delivers game-changing features that place the patients at the centre… This is why Doxx is backed by Egyptian doctors who truly believe that, with the right tools, Egypt will be able to transform its healthcare system,” said Heba Saher Hashem — Consultant of Neurology and Doxx Investor.
“Elevate’s investment in Doxx is part of our fundamental commitment to elevating access to quality healthcare in Egypt and Sub-Saharan Africa. This is the first of a series of investments in healthcare start-ups as part of Elevate’s healthcare-focused venture capital platform, with our participation in Doxx being a warehousing effort,” said Tarek Moharram — Group CEO of Elevate PE and Elevate Healthcare.
We believe that Egypt’s technological innovation, creativity and agility, as well as the large supply/demand gap in quality healthcare service, are all factors that will allow it to become a regional hub. Elevate wants to be the engine that drives this growth. We are excited to see the potential of Doxx as part this vision.